IP Verse

Polpharma Biologics S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Polpharma Biologics S.a.

Patent Number:
EP3339865
Title:
Assay For Jc Virus Antibodies
Applicant:
BIOGEN MA INC.
Opposition Date:
May 23, 2023
Patent Number:
EP3575792
Title:
Method Of Assessing Risk Of Pml
Applicant:
BIOGEN MA INC.
Opposition Date:
Dec 1, 2022
Patent Number:
EP3095463
Title:
Methods For Treating Progressive Multiple Sclerosis
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Jun 8, 2021
Patent Number:
EP3264094
Title:
Methods For Evaluating An Immune Response To A Therapeutic Agent
Applicant:
BIOGEN MA INC.
Opposition Date:
May 18, 2021
Patent Number:
EP2676967
Title:
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
May 14, 2020
Patent Number:
EP2715352
Title:
Method Of Assessing Risk Of Pml
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Jan 17, 2020

Competitors of Polpharma Biologics S.a.

BIOGEN MA INC.

BIOGEN IDEC MA INC.

F. HOFFMANN-LA ROCHE AG

Want to track Polpharma Biologics S.a.?

Feel free to send us a message here and we will get back to you